Skip to main content
VCbacked
Log inGet Started

Editas Medicine

Cambridge, United States

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

$125.0M raised
May 2026
Post-IPO Equity
BiotechnologyGeneticsHealth CareMedical

Top Investors

Khosla VenturesOmega FundsFidelityThird Rock VenturesGoogle Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Editas Medicine

How much funding has Editas Medicine raised?
Editas Medicine has raised $125.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Who are Editas Medicine's investors?
Editas Medicine's investors include Khosla Ventures, Omega Funds, Fidelity, Third Rock Ventures, Google Ventures.
Where is Editas Medicine headquartered?
Editas Medicine is headquartered in Cambridge, United States.
What does Editas Medicine do?
Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.
What stage is Editas Medicine at?
Editas Medicine is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Editas Medicine — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/editas-medicine. Accessed July 3, 2026.
APA
VCBacked. (2026). Editas Medicine — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/editas-medicine
Wikipedia (cite web)
{{cite web |title=Editas Medicine — Funding & Investors |url=https://www.vcbacked.co/company/editas-medicine |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K